Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q4 2023 Earnings

21MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.89

-0.59

-0.3

0

Details

Expected EPS

-0.825

Actual EPS

-0.61

Surprise EPS

0.21

Surprise Percent

+26.06%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.61 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.